News

Physical inactivity is a risk factor for several chronic diseases, especially among older adults. Conversely, engaging in regular physical activity reduces the risk for these chronic diseases and has been known to improve cognitive function, physical function and quality of life among older adults.
KL2 scholar Jordan Schultz and his research team receive an Accelerator Grant from the Iowa Neuroscience Institute to support high-impact neuroscience research.
Using the UI’s Human Performance and Clinical Outcomes Laboratory, researchers are studying devices that could help military veterans and civilians who have suffered limb trauma.
Boyd Knosp, MS, has been awarded the designation of Fellow of the American Medical Informatics Association (AMIA).
Science on Tap is an informal forum for University of Iowa researchers to engage the campus and the local community in a discussion of science in a fun and inviting atmosphere, while recognizing the great research and scholarship taking place at Iowa. Check out the schedule of speakers for Fall 2019 and Spring 2020.
The University of Iowa honors faculty and staff each year for their dedication, service, and excellence at the University of Iowa’s annual Faculty and Staff Awards celebration. This year, eighteen faculty and staff members were selected. Two of those honorees are members of the Institute for...
Patricia Winokur, MD, Co-Director of ICTS, and other University of Iowa researchers are conducting a clinical trial for an enhanced flu vaccine.
Jackline Wangui-Verry, MSN, RN-BC, assistant director of the Clinical Research Unit, explored the topic of milk and molasses enemas to evaluate the safety and efficacy for hospitalized adults with unresolved constipation after standard treatment options failed.
Conference participants will learn strategies for applying evidence that improves team functioning, strategies to apply implementation and team science, network with EBP experts and enthusiasts, while learning cutting edge information to apply across settings.
Phil Polgreen, MD, associate director of the mobile technology lab, and pilot grant awardee Nandakumar Narayanan, MD, PhD, are on research team that found a drug used to treat enlarged prostate may also be able to slow the progression of Parkinson’s disease.